InsiderTrades

Form 4 for LAB STANDARD BIOTOOLS INC.

Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0000950170-24-098700 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-19 2024-08-15 LAB Black Jeffrey G. SVP, CFO F - Tax $1.55 -4,695 428.3K -1% -$7,277
D 2024-08-19 2024-08-15 LAB Black Jeffrey G. SVP, CFO M - OptEx $0.00 +13.2K 433.0K +3% $0
D 2024-08-19 2024-08-15 LAB Black Jeffrey G. SVP, CFO M - OptEx $0.00 -13.2K 144.7K -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-15 F D 4,695 $1.55 428,298 D — — (F1) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 15, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023.
2 Common Common Stock 2024-08-15 M A 13,157 $0.00 432,993 D — —
3 Derivative Restricted Stock Units 2024-08-15 M D 13,157 $0.00 144,738 D — · — to — 13,157 Common Stock (F2) Each RSU represents the contingent right to receive one share of the Issuer's common stock. (F3) On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and 1/16th of the RSUs vested on August 15, 2024. The remaining unvested RSUs will be forfeited due to the resignation of the Reporting Person effective as of August 31, 2024.